UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 527

Sortiert nach

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8447-8452

2005

Volltextzugriff (PDF)

Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

Journal of clinical oncology, 2004-08, Vol.22 (15), p.3046-3052

2004

Volltextzugriff (PDF)

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

The New England journal of medicine, 2004-11, Vol.351 (21), p.2159-2169

2004

Volltextzugriff (PDF)

A Clinical Analysis of Two Indolent Lymphoma Entities: Mantle Cell Lymphoma and Marginal Zone Lymphoma (Including the Mucosa-Associated Lymphoid Tissue and Monocytoid B-Cell Subcategories): A Southwest Oncology Group Study

Blood, 1995-02, Vol.85 (4), p.1075-1082

1995

Volltextzugriff (PDF)

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Cancer cell, 2003-02, Vol.3 (2), p.185-197

2003

Volltextzugriff (PDF)

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition : Therapeutic implications

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (14), p.6294-6304

2005

Volltextzugriff (PDF)

The limits of limited stage lymphoma

Journal of clinical oncology, 2004-08, Vol.22 (15), p.2982-2984

Miller, Thomas P

2004

Volltextzugriff (PDF)

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

The New England journal of medicine, 1998-07, Vol.339 (1), p.21-26

1998

Volltextzugriff (PDF)

Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4390-4398

2005

Volltextzugriff (PDF)

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

Blood, 1994-03, Vol.83 (6), p.1460-1466

1994

Volltextzugriff (PDF)

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Molecular cancer therapeutics, 2005-12, Vol.4 (12), p.1867-1879

2005

Volltextzugriff (PDF)

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Blood, 2003-09, Vol.102 (5), p.1606-1612

2003

Volltextzugriff (PDF)

Prognostic significance of the Ki-67 : associated proliferative antigen in aggressive non-Hodgkin's lymphomas : a prospective Southwest oncology group trial

Blood, 1994-03, Vol.83 (6), p.1460-1466

1994

Volltextzugriff (PDF)

Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas

Laboratory investigation, 2003-02, Vol.83 (2), p.271-285

2003

Volltextzugriff (PDF)

Phase III Randomized Intergroup Trial of Subtotal Lymphoid Irradiation Versus Doxorubicin, Vinblastine, and Subtotal Lymphoid Irradiation for Stage IA to IIA Hodgkin’s Disease

Journal of clinical oncology, 2001-11, Vol.19 (22), p.4238-4244

2001

Volltextzugriff (PDF)

Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell death

The Journal of biological chemistry, 2006-01, Vol.281 (2), p.1107

2006

Volltextzugriff (PDF)

REM Sleep Behavior Disorder: Potential Relationship to Post-traumatic Stress Disorder

Journal of clinical neurophysiology, 2001-03, Vol.18 (2), p.148-157

2001

Volltextzugriff (PDF)

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Blood, 2001-06, Vol.97 (12), p.3713-3720

2001

Volltextzugriff (PDF)

Dose-Intense Chemotherapy Every 2 Weeks With Dose-Intense Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone May Improve Survival in Intermediate- and High-Grade Lymphoma: A Phase II Study of the Southwest Oncology Group (SWOG 9349)

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2466-2473

2003

Volltextzugriff (PDF)

Independent Prognostic Significance of a Nuclear Proliferation Antigen in Diffuse Large Cell Lymphomas as Determined by the Monoclonal Antibody Ki-67

Blood, 1988-04, Vol.71 (4), p.1157-1160

1988

Volltextzugriff (PDF)

Combination of Fludarabine and Mitoxantrone in Untreated Stages III and IV Low-Grade Lymphoma: S9501

Journal of clinical oncology, 2003-05, Vol.21 (10), p.1996-2003

2003

Volltextzugriff (PDF)

Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma

Clinical cancer research, 2000-10, Vol.6 (10), p.3904-3909

2000

Volltextzugriff (PDF)

Lack of cost-effectiveness of omalizumab

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.429-430

2005

Volltextzugriff (PDF)

1 – 25 von 527

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(469)
Mit Volltextzugriff
(444)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(470)
Life Sciences & Biomedicine
(358)
Humans
(238)
Biological And Medical Sciences
(169)
Female
(146)
Male
(143)
Medical Sciences
(131)
Middle Aged
(103)
Adult
(98)
Animals
(98)
Physical Sciences
(89)
Oncology
(80)
Aged
(78)
Pharmacology. Drug Treatments
(49)
Pharmacology & Pharmacy
(43)
Fundamental And Applied Biological Sciences. Psychology
(40)
Technology
(37)
Biochemistry & Molecular Biology
(34)
Medicin Och Hälsovetenskap
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

A Clinical Analysis of Two Indolent Lymphoma Entities: Mantle Cell Lymphoma and Marginal Zone Lymphoma (Including the Mucosa-Associated Lymphoid Tissue and Monocytoid B-Cell Subcategories): A Southwest Oncology Group Study

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition : Therapeutic implications

The limits of limited stage lymphoma

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Prognostic significance of the Ki-67 : associated proliferative antigen in aggressive non-Hodgkin's lymphomas : a prospective Southwest oncology group trial

Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Phase III Randomized Intergroup Trial of Subtotal Lymphoid Irradiation Versus Doxorubicin, Vinblastine, and Subtotal Lymphoid Irradiation for Stage IA to IIA Hodgkin’s Disease

Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell death

REM Sleep Behavior Disorder: Potential Relationship to Post-traumatic Stress Disorder

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Dose-Intense Chemotherapy Every 2 Weeks With Dose-Intense Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone May Improve Survival in Intermediate- and High-Grade Lymphoma: A Phase II Study of the Southwest Oncology Group (SWOG 9349)

Independent Prognostic Significance of a Nuclear Proliferation Antigen in Diffuse Large Cell Lymphomas as Determined by the Monoclonal Antibody Ki-67

Combination of Fludarabine and Mitoxantrone in Untreated Stages III and IV Low-Grade Lymphoma: S9501

Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma

Lack of cost-effectiveness of omalizumab

Suchergebnisse filtern